BackActuate Therapeutics Overview

Actuate Therapeutics Other Current Assets

Track Actuate Therapeutics's other current assets ($390K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$385444.00
7.32% YoYΔ $26285.00 vs prior year quarter

Peer average

Loading

Actuate Therapeutics Other Current Assets History

Loading

Actuate Therapeutics vs. peers: Other Current Assets Comparison

Loading

Actuate Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Actuate Therapeutics (ACTU) FAQ

As of the most recent data (March 2026), ACTU shows a other current assets of $390K. That compares with $360K in the prior-year period — up 7.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACTU's other current assets is now $390K (was $360K) — a 7.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Actuate Therapeutics is outperforming or lagging.

Tracking ACTU's other current assets over time shows whether Actuate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $390K That compares with $360K in the prior-year period — up 7.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Actuate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $390K) with ownership activity and broader fundamentals.